ABSTRACT. Background: This case report describes our pre liminary data on the use of taurolidine as a lock technique. Taurolidine is a novel antimicrobial agent that has found a niche in Europe for prevention of bacteremia in home parenteral nutri tion (HPN) patients who have multiple catheter·related blood· stream infections. Methods: A 29·year-old male with short bowel syndrome was admitted 18 times in 9 years for treatment of Gram-(Wositive, Gram-negative, and yeast-associated catheter-related
CASE REPORT
A 29-year-old male with short bowel syndrome pre sented every 2 to 6 months with chills and fevers. After an initial proctocolectomy for intractable ulcerative colitis in childhood, 12 years later after an acute throm boembolic event to his superior mesenteric artery, the patient underwent massive bowel resection, resulting in a high-output jejunostomy. An extensive hypercoaguia bility evaluation was negative. In the past 9 years, the patient had presented 18 times with CRBSIs (Table I) . The catheter was replaced 10 times. During the initial 2 years of canalization, catheter re moval was required for each CRBSI, either because of overwhelming infection with evidence of progressive end organ failure or apparently because of failure to eliminate bacteremia. . For the first series of CRBSIs with an implanted pe ripherally inserted port in the right arm, catheter sal vage was possible using both systemic and intraluminal antibiotic therapy.
A number of line changes followed shortly thereafter.
In this series, in addition to being bacteremic, the pa tient presented with either erythema at the port inser tion site or pus draining from the site.
From this point onward, access site care was provided exclusively and regularly by the Total Parenteral N utri tion (TPN) Nurse in a clinic setting. Evaluation of the patient's protocol for site care and sterilization of the skin and catheter hub, aseptic technique, and stoma site care, as well as the type of dressings used, was satisfac tory and failed to reveal anything remarkable. The pro tocol and frequency of site care and technique, includ ing alcohol swabbing of the catheter hub, remained unchanged over the course of the patient's treatment. After four more CRBSIs within the span of 16 months, the TPN team contemplated the use of taurolidine to in terrupt this pattern. The daily 1.5 mL heparin, 100 units! mL, was replaced with 1.5 mL of taurolidine 2%. Radio logic investigation shoWed the volume of the implanted port and its extension to total 1.5 mL. The solution was left indwelling for 12 hours and then was flushed through Qefore the infusion of the HPN solution. Although anti microbial locks often are aspirated after indwelling, the patient's port did not allow aspiration except immedi ately after flushing.
The patient remained infection-free for la months. It must be pointed out that this prophylaxis modality was not undertaken with a fresh catheter. The risk of a sub clavian thrombosis precluded the replacement of the existing catheter and port.
The patient presented at the la-month mark into the prophylaxis regimen with severe bone pain. Because osteomyelitis initially had not been ruled out of the dif ferential diagnosis, peripheral and retrograde blood samples were taken and proved to be positive. The right arm port and catheter were removed promptly and sys temic antibiotic treatment was implemented. A single lumen tunneled catheter then was inserted and subse quently the diagnosis of TPN osteodystrophy was made.
The patient has remained infection-free for 12 months to the present date using 3 mL taurolidine daily.
DISCUSSION
The subset ofHPN patients who have recurrent CRBSIs despite the most meticulous aseptic technique and provisions for intestinal stomas, pose a considerable thera peutic challenge. Our own experience with recurrent CRBSIs suggests that conventional systemic therapy with antibiotics complemented with antibiotic lock tech nique and catheter replacement was not successful in stopping recurrence. The use of the antimicrobial taurolidine was successful in interrupting the pattern of recurrent infection even in a line that had been previ ously endolurninally infected.
Taurolidine has been used extensively for its antimi crobial and antiendotoxemic properties, particularly in peritonitis. I.," It is a nonantibiotic agent and is chemi cally derived from the aminosulphonic acid taurine, with complete coverage of Gram-positive, Gram-negative, and fungal organisms. Ta either the bacterial or the epithelial cell is exposed to taurolidine and is time-and concentration-dependent.17
The ability of the drug to protect pretreated epithelial cells from colonization by bacteria is of particular inter est in its application in the prophylaxis of infe.ction. 
